Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.21.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Stockholders' equity:  
Schedule of stock options issued by the Company

  Options
Outstanding
    Options
Exercisable
    Range of
Exercise Prices
    Weighted-average
Exercise price
per share
    Intrinsic
Value(1)

(in thousands) 
 
Outstanding at January 1, 2019   1,386,396         $ 1.40     $ 385.60     $ 11.09     $ 11  
Exercisable at January 1, 2019         973,498                                
Activity during the year ended December 31, 2019                                            
Granted   256,601             1.65       4.11       3.44       349  
Exercised   (3,025 )           1.74       2.60       1.89          
Cancelled or forfeited   (805 )           2.60       385.60       95.37          
Outstanding at December 31, 2019   1,639,167             1.40       83.60       9.87       2,892  
Exercisable at December 31, 2019         1,293,121                               2,245  
Activity during the year ended December 31, 2020                                            
Granted   264,268             3.24       5.85       4.34       3,052  
Exercised   (30,958 )           1.40       5.00       2.47          
Cancelled or forfeited   (66,385 )           72.00       72.00       72.00          
Outstanding at December 31, 2020   1,806,092           $ 1.40     $ 83.40     $ 7.12     $ 20,760  
Exercisable at December 31, 2020         1,511,938                             $ 17,287  

 

(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.

 

Schedule of company's nonvested stock options
Nonvested Stock Options   Shares     Weighted-Average Per Share Grant Date Fair Value  
Nonvested, January 1, 2019     380,283     $ 1.21  
Activity during the year ended December 31, 2019                
Granted     256,601       1.72  
Exercised     (2,725 )     0.93  
Forfeited     (580 )     42.66  
Vested     (287,533 )     1.35  
Nonvested, December 31, 2019     346,046     $ 1.46  
Activity during the year ended December 31, 2020                
Granted     264,268       2.22  
Exercised     (30,958 )     1.23  
Forfeited     (60,830 )     33.20  
Vested      (224,372 )      1.50  
Nonvested, December 31, 2020     294,154     $ 2.09  
Schedule of share-based compensation expense

Years Ended December 31,

(in thousands)

2020     2019  
$     1,090   $     799  

 

Schedule of assumptions used in calculating the fair value under the Black-Scholes option-pricing model
    Years Ended December 31,  
    2020     2019  
Dividend yield   0%     0%  
Expected Volatility   56.05% - 57.00%     52.17% to 52.90%  
Risk free Interest rates   0.34% - 0.49%     1.39% to 1.72%  
Expected lives (in years)   5.5 to 6.0     5.5 to 6.0  

 

Schedule of common stock warrant activity
    Shares     Weighted - Average
Exercise
Price
 
Outstanding at January 1, 2019   8,676,481     $ 4.17  
Activity during the year ended December 31, 2019              
Exercised   (2,928,681 )     2.20  
Terminated   (215,533 )     35.32  
Outstanding at December 31, 2019   5,532,267       4.00  
Activity during the year ended December 31, 2020              
Exercised   (2,163,042 )     2.36  
Terminated   (286,238 )     18.31  
Outstanding at December 31, 2020   3,082,987     $ 3.82  

 

Schedule of information regarding outstanding warrants
Exercise
Price
    Number
Outstanding
    Weighted-Average
Remaining
Contractual Life
    Intrinsic Value
(in thousands)(1)
 
                     
$ 2.20       1,967,750       1.42     $ 26,938  
  5.50       1,004,955       0.67       10,441  
  16.23       80,490       2.37        
$ 21.10       29,792       0.25        
          3,082,987       1.19     $ 37,379  

 

(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at December 31, 2020 less the warrant exercise price of in-the-money warrants.